Found 9 matching trials
A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer PHASE2 This is a prospective , single - arm clinical study , aiming to evaluate th...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer PHASE1 This trial is an open-label, dose-escalation, and randomized controlled Pha...
Show More Location
Multiple Locations
Learn More & Join Trial
SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma PHASE2 This study is a n open-label, multi-center, phase II study to evaluate the ...
Show More Location
Shanghai East Hospital Affiliated To Tongji University
Learn More & Join Trial
SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer PHASE2 Efficacy and Safety of SYHX2011 Combined with Carboplatin and Enlonstobart ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC) PHASE3 The purpose of the study is to compare the efficacy and safety of SYS6010 i...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer PHASE2 Phase II - Treatment Regimen Exploration Stage:
1. Evaluate the safety and...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial
SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid Tumors PHASE1 This study is a Phase Ib/II clinical study. It includes two stages: Phase I...
Show More Location
Multiple Locations
Learn More & Join Trial
SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC(SYNSTAR 04) PHASE3 This study was an open-label, multi-center, randomized phase III study to e...
Show More Location
Multiple Locations
Learn More & Join Trial
SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC PHASE2 This is a Phase II study of anti-nectin-4 ADC combined with the EGFR monocl...
Show More Location
Multiple Locations
Learn More & Join Trial